We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

84 hedge funds and large institutions have $268M invested in Akcea Therapeutics Inc in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

9% more funds holding

Funds holding: 77 → 84 (+7)

8% less capital invested

Capital invested by funds: $292M → $268M (-$23.9M)

11% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $1.45M

Holders
84
Holders Change
+7
Holders Change %
+9.09%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
38
Reduced
18
Closed
11
Calls
$1.3M
Puts
$1.45M
Net Calls
-$156K
Net Calls Change
+$217K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.57M
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.11M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.09M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.97M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.11M

Top Sellers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
-$26.9M
2
State Street
State Street
Massachusetts
-$5.53M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.32M
4
Millennium Management
Millennium Management
New York
-$1.21M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$8K – – –
SFS
77
Sowell Financial Services
Arkansas
$6K +$6.73K +436 New
UBS Group
78
UBS Group
Switzerland
$5K -$6.68K -433 -56%
CFA
79
Carroll Financial Associates
North Carolina
$3K – – –
SIM
80
Sonora Investment Management
Arizona
$1K – – –
Millennium Management
81
Millennium Management
New York
– -$1.21M -84,871 Closed
Russell Investments Group
82
Russell Investments Group
United Kingdom
– -$1M -69,964 Closed
Squarepoint
83
Squarepoint
New York
– -$985K -68,847 Closed
Susquehanna International Group
84
Susquehanna International Group
Pennsylvania
– -$516K -33,430 Closed
Mackenzie Financial
85
Mackenzie Financial
Ontario, Canada
– -$421K -29,430 Closed
GAM
86
Gotham Asset Management
New York
– -$260K -18,189 Closed
DTL
87
Dynamic Technology Lab
Singapore
– -$241K -16,826 Closed
EGM
88
Engineers Gate Manager
New York
– -$145K -10,121 Closed
Lazard Asset Management
89
Lazard Asset Management
New York
– -$67K -4,731 Closed
Victory Capital Management
90
Victory Capital Management
Texas
– -$36K -2,448 Closed
CG
91
Cutler Group
California
– -$27K -1,899 Closed
QT
92
Quantbot Technologies
New York
– +$309 +20 New
Simplex Trading
93
Simplex Trading
Illinois
– +$633 +41 New
BCA
94
Berman Capital Advisors
Georgia
– +$1.05K +68 New
GT
95
Glenmede Trust
Pennsylvania
– +$1.05K +68 New
1 2 3
4

AKCA Hedge Fund Activity: Q2 2020 in Review

84 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q2 2020, worth a combined $268M — down 8.2% from $292M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AKCA positions and 11 closed out — a net gain of 7 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $7.57M. The largest seller was Bellevue Group, cutting an estimated $26.9M.

  • 84 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q2 2020, up from 77 in Q1 2020.
  • Funds reported $268M of Akcea Therapeutics Inc stock for Q2 2020, down 8.2% quarter-over-quarter.
  • 18 funds opened new Akcea Therapeutics Inc positions in Q2 2020 and 11 closed out, a net change of +7 holders.
  • The largest Akcea Therapeutics Inc buyer in Q2 2020 was BlackRock, an estimated $7.57M added.
  • The largest Akcea Therapeutics Inc seller in Q2 2020 was Bellevue Group, an estimated $26.9M sold.

Based on aggregated 13F filings for Q2 2020.